Post Approval Study of the Eversense® Continuous Glucose Monitoring

Completed · Not applicable

Conditions studied: Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

In brief

A Post Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System over repeat insertion and removal cycles and to demonstrate the long-term safety of the Eversense® CGM System

Key facts

Study ID
NCT03908125
Run by
Senseonics, Inc.
People needed
273
Starts
2019-03-19
Expected to finish
2024-02-01
Last updated by the study team
2025-06-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.